Bio-Rad Laboratories (BIO-B) Return on Capital Employed (2010 - 2026)

Bio-Rad Laboratories (BIO-B) has 17 years of Return on Capital Employed data on file, last reported at 0.62% in Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 0.62%, down 511.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.62% (down 511.0% YoY), and the FY2025 annual result was 0.5%, down 588.0% from the prior year.
• Return on Capital Employed rose to 0.62% in Q1 2026 per BIO-B's latest filing, from 0.49% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 8.84% in Q4 2022 and troughed at 100.1% in Q1 2024.
• A 5-year average of 3.0% and a median of 4.15% in 2022 frame the typical range for Return on Capital Employed.
• The sharpest annual moves came in 2024 and 2025: Return on Capital Employed sank 10648 bps in 2024, then jumped 10583 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 8.84% in 2022, then fell by 30 bps to 6.23% in 2023, then plunged by 1708 bps to 100.1% in 2024, then jumped by 100 bps to 0.49% in 2025, then gained by 27 bps to 0.62% in 2026.
• Business Quant data shows BIO-B's Return on Capital Employed at 0.62% in Q1 2026, 0.49% in Q4 2025, and 2.38% in Q3 2025.